Health Condition 1: K132- Leukoplakia and other disturbancesof oral epithelium, including tongue Health Condition 2: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx Health Condition 3: K135- Oral submucous fibrosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Study subjects who have given written informed consent Control group without tobacco habit Subjects clinically diagnosed with OPMDS and OSCC
Exclusion criteria
Exclusion criteria: Subjects who had undergone treatment for malignancy Subjects with recurrence of OSCC Subjects with co-existing malignancy Immune-compromised subjects and those suffering from chronic debilitating diseases such as diabetes, tuberculosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Development of point of care cytology screening tool and deep learning model for screening of OPMDs and OSCC.Timepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Validation of the tool gaining acceptance among healthcare providers in remote setting areas.Timepoint: Baseline | — |
Countries
India
Contacts
Datta Meghe Institute of Higher Education and Research